Remove Business Development Remove Gene Sequencing Remove Genomics Remove Licensing
article thumbnail

Oxford Nanopore makes stellar debut on UK stock market

pharmaphorum

It has made Oxford Nanopore’s chief executive and cofounder Gordon Sanghera an on-paper fortune of £63 million, while another cofounder – chief business development officer Spike Willcocks – is now worth £30 million. Chief technology officer Clive Brown is also sitting on a £10 million stake.